Delivery Order SPE2DR25D1205-SPE2DR26F0YD1
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $7,892.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,294.72 for 60-count tablets of Eliquis 5 mg on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract ceiling value of $3,738.28. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is scheduled for completion by May 13, 2025, with performance based at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $17,565.91 under a firm fixed-price contract type. This competitively awarded, non-set-aside delivery order is scheduled for completion by November 19, 2025, and represents a child contract executed under AmerisourceBergen's larger indefinite delivery vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) under a firm fixed-price contract valued at $9,814.06. The award, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract vehicle. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,558.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on December 10, 2025, with completion scheduled for December 11, 2025. The contract employs firm fixed-price terms and carries no set-aside designation, indicating competitive award to this pharmaceutical distributor. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical...
- The Defense Logistics Agency awarded a $18,761.49 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 14, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $2,291.43. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of December 3, 2025, and represents a single-line pharmaceutical procurement executed through the company's existing contract vehicle. The performance location is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp was awarded a delivery order for ELIQUIS 5 mg tablets (60-count supply) by the Defense Logistics Agency on November 13, 2025, with a ceiling value of $34,758.53. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is expected to be completed by November 14, 2025. This award is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0YD1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $4,437.77. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order falls under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor, AmerisourceBergen provides critical medical commodities to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The contract award demonstrates AmerisourceBergen's continued role as a prime vendor for federal medical procurement and its capability to meet DLA requirements through open competition without set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/10/25 |